Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 19-Jun-2013
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 13)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
18-Jun-13Thomson Reuters Stock ReportStockReports + Research DepartmentThomson Reuters Stock Report - ABBVIE INC (ABBV-N)12$25  View Abstract
17-Jun-13Market EdgeN/AMarket Edge Equity Research Report4$10  View Abstract
15-Jun-13S&P Capital IQ – STARS ReportsN/AAbbVie Inc10$115  View Abstract
14-Jun-13Ford Investor Services, Inc.N/AValue Graph: ABBVIE -- ABBV1$11.50  View Abstract
14-Jun-13Ford Investor Services, Inc.N/AIndustry Value Graph: ABBV , AZN , GSK , MRK , NVS , PFE , RHHBY -- DRUGS3$34.50  View Abstract
7-Jun-13GlobalDataGlobalDataAbbVie Inc. (ABBV) - Financial Analysis Review42$125  View Abstract
4-Jun-13Thomson Reuters StreetEventsResearch DepartmentABBV.N - Event Transcript of AbbVie Inc conference call, Jun. 04, 2013 / 9:00AM ET8$75  View Abstract
3-Jun-13Zacks Investment Research Inc.N/AABBVIE INC (ABBV) Zacks Company Snapshot1$11.50  View Abstract
30-May-13Streetwise ReportsN/ANew Perspectives and Seven Biotechs for a Diversified Portfolio: Ori Hershkovitz8$80.50  View Abstract
17-May-13Zacks Investment Research Inc.N/AABBVIE INC (ABBV) Zacks Company Snapshot1$11.50  View Abstract
Next 3

Independent Reports (Showing 1 to 10 of 13)
Release
Date
 [down]
Contributor Author Title Pages Price More Info
18-Jun-13Thomson Reuters Stock ReportStockReports + Research DepartmentThomson Reuters Stock Report - ABBVIE INC (ABBV-N)12$25View Abstract
17-Jun-13Market EdgeN/AMarket Edge Equity Research Report4$10View Abstract
15-Jun-13S&P Capital IQ – STARS ReportsN/AAbbVie Inc10$115View Abstract
14-Jun-13Ford Investor Services, Inc.N/AValue Graph: ABBVIE -- ABBV1$11.50View Abstract
14-Jun-13Ford Investor Services, Inc.N/AIndustry Value Graph: ABBV , AZN , GSK , MRK , NVS , PFE , RHHBY -- DRUGS3$34.50View Abstract
7-Jun-13GlobalDataGlobalDataAbbVie Inc. (ABBV) - Financial Analysis Review42$125View Abstract
4-Jun-13Thomson Reuters StreetEventsResearch DepartmentABBV.N - Event Transcript of AbbVie Inc conference call, Jun. 04, 2013 / 9:00AM ET8$75View Abstract
3-Jun-13Zacks Investment Research Inc.N/AABBVIE INC (ABBV) Zacks Company Snapshot1$11.50View Abstract
30-May-13Streetwise ReportsN/ANew Perspectives and Seven Biotechs for a Diversified Portfolio: Ori Hershkovitz8$80.50View Abstract
17-May-13Zacks Investment Research Inc.N/AABBVIE INC (ABBV) Zacks Company Snapshot1$11.50View Abstract
Next 3

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.


Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.